Sepsis costs Medicare more than hip replacements, heart failure, and acute MI combined. Over the eleven years from 2013 to 2023, a single DRG code, 871 (septicemia or severe sepsis without mechanical ventilation greater than 96 hours, with major complication or comorbidity), generated $77,974,339,350 in total Medicare payments. The next closest DRG, major hip and knee joint replacement (DRG 470), reached $44,712,706,219 over the same period. That's a gap of roughly $33 billion, and it comes from one code alone.

Add the two other sepsis DRGs and the picture gets starker. DRG 870 (sepsis with mechanical ventilation) contributed another $14,666,827,765 across 311,704 discharges. DRG 872 (sepsis without MV, without MCC) added $9,802,110,513 across 1,461,431 discharges. The three codes together account for over $102 billion in Medicare payments from 2013 to 2023. No other condition cluster comes close.

Volume Drove the Bill, Not Just Acuity

The scale of DRG 871 spending reflects volume as much as cost per case. Discharges under that code grew from 403,847 in 2013 to 622,866 in 2018, an increase of 219,019 discharges in five years. Average payment per discharge rose more modestly, from $11,977 in 2013 to $12,622 in 2019. The math is straightforward: when you're billing more than 600,000 cases a year at roughly $12,000 each, the aggregate becomes enormous fast.

For context, DRG 470 (hip and knee replacement) covered 3,724,307 total discharges over the same eleven-year window, more than half the volume of DRG 871 alone, yet generated $33 billion less in total payments. Sepsis cases are not dramatically more expensive per admission than joint replacements. They're just far more numerous, and the patients are far sicker on arrival, which drives MCC coding and keeps them in the highest-cost DRG tier.

A $9,000 Gap Between States That Demands Explanation

In 2023, California led the country with 82,313 sepsis discharges (11.99% of all national sepsis discharges) and $1,641,304,230 in total Medicare sepsis payments. But the state-level payment variation is where the data gets genuinely difficult to interpret. Average Medicare payment per sepsis discharge ranged from $12,141 in Tennessee to $21,441 in Maryland, a spread of more than $9,000 per case. California's average of $19,940 sits near the top of that range.

That gap matters because it translates directly into taxpayer dollars at scale. If Tennessee's per-discharge rate applied to California's 82,313 discharges, total Medicare payments for California sepsis in 2023 would have been roughly $1 billion rather than $1.64 billion. Whether the difference reflects higher hospital wages, more complex case mixes, coding intensity, or market-specific payment rates, the variation is large enough that it can't be dismissed as noise.

The Spending Baseline Has Already Shifted

The conventional framing of Medicare inpatient cost drivers centers on elective procedures: joint replacements, cardiac interventions, spinal fusions. That framing is now outdated. DRG 871 alone outspent major hip and knee replacement by $33 billion over eleven years. Heart failure with MCC (DRG 291), the third-highest DRG by total payment, reached $30,988,200,151 over the same period, less than 40% of what DRG 871 generated.

Sepsis is not a surgical line item that can be managed through utilization review or prior authorization. It arrives through the emergency department, often in elderly patients with multiple comorbidities, and the clinical pathway offers limited room for cost reduction once a patient is admitted. The $102 billion total across all three sepsis DRGs from 2013 to 2023 represents a structural feature of Medicare inpatient spending, not an anomaly. Any serious analysis of what Medicare actually pays for has to start here.